Accolade Inc
NASDAQ:ACCD
Accolade Inc
NASDAQ:ACCD
Price:
7.5 USD
-1.7%
Updated:
May 1, 2024
EV/IC
Enterprise Value to IC
Enterprise Value to IC
1
Current
1.5
Median
2
Industry
Lower
than median
Lower
than industry value
Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.
EV/IC
=1
Enterprise Value
/
565.4m
Invested Capital
542.8m
All Countries
| Market Cap | EV/IC | ||||
|---|---|---|---|---|---|
| US |
|
Accolade Inc
NASDAQ:ACCD
|
575.7m USD | 1 | |
| US |
|
Cigna Corp
NYSE:CI
|
104B USD | 0.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
96.9B EUR | 0.9 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
70.2B USD | 0.7 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.7B EUR | 1 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
16.9B USD | 1.3 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.8B EUR | 0.7 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.2B USD | 1.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.6B EUR | 0.7 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.3B USD | 1.3 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 6.2 |
EV/IC Forward Multiples
Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/IC
N/A
2-Years Forward
EV/IC
N/A
3-Years Forward
EV/IC
N/A
You don't have any saved screeners yet
